Apollo Grant

Program Type: Research Grant

Geographic Scope: Global

Focus Area: Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) research

Description:
Part of The MOG Project's Research for Rare program, the Apollo Grant provides funding to develop hypotheses and gather seed/pilot data to support and strengthen the submission of a future same subject proposal. This allows investigators to better secure greater funding from larger organizations.

Funding Purpose:
The grants are intended to support the advancement of medical knowledge and understanding of MOGAD, a rare neuroinflammatory condition that attacks the optic nerve, brain, and/or spinal column, leading to better diagnosis, targeted treatments, and eventually a cure.

Organization Background:
The MOG Project is a 501(c)(3) nonprofit organization dedicated to funding researchers to advance understanding, prediction, treatment, and eventual cure of MOGAD.

Recent Award Examples (2025):

• Maria Hastermann, MD, PhD, Nadine Strempel, PhD, Professor Enrico Klotzsch, PhD and Professor Friedemann Paul of Charité Universitätsmedizin Berlin - "Mechanostimulation of MOG-Specific Regulatory T-cells"
• Kevin C. O'Connor, PhD and Erin Longbrake, MD, PhD, of Yale University School of Medicine - "Leveraging MOG-Specific Human Monoclonal Autoantibodies to Describe Mechanisms of Immunopathology"

Eligibility: Research institutions and individual researchers studying MOGAD

Contact Information:

• Website: mogproject.org
• See website for detailed contact information